ImportRefusal LogoImportRefusal

Bloomage Biotechnology Corp., Ltd.

⚠️ Moderate Risk

FEI: 3008240723 • Jinan, Shandong • CHINA

FEI

FEI Number

3008240723

📍

Location

Jinan, Shandong

🇨🇳

Country

CHINA
🏢

Address

678 Tianchen Road, Hi-Tech Development Zone, , Jinan, Shandong, China

Moderate Risk

FDA Import Risk Assessment

38.3
LowModerateHighCritical

This firm has a moderate history of FDA import refusals. Some attention may be warranted.

Statistics

8
Total Refusals
8
Unique Violations
12/9/2020
Latest Refusal
10/14/2003
Earliest Refusal

Score Breakdown

Violation Severity
68.2×40%
Refusal Volume
35.3×30%
Recency
0.0×20%
Frequency
4.7×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

1183×

NOT LISTED

It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).

2372×

NO PMA

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that the device appears to be a Class III device and does not appear to have in effect an approved application for premarket approval pursuant to Section 515 of the Act, or an exemption pursuant to Section 520(g)(1).

23801×

NO PMA/PDP

The article appears to be a class III dev.w/o an approved applic. for premarket approval, and/or a notice of completion of product development protocol filed per section 515(b) or exempt per sect.520(g)(1).

32801×

FRNMFGREG

The article is subject to refusal of admission pursuant to section 801(a)(3) in that it appears to be misbranded as defined in section 502(o) of the FD&C Act. It appears that it was manufactured, prepared, propagated, compounded, or processed in an establishment not duly registered under section 510 of the Act.

721×

NEW VET DR

The article is subject to refusal of admission pursuant to Section 801(a)(3) of the Federal Food, Drug, and Cosmetic Act in that it appears to be a new animal drug that is unsafe within the meaning of Section 512(a) of the Federal Food, Drug, and Cosmetic Act as it is not the subject of an approved new animal drug application, conditionally approved new animal drug application, or index listing, and no investigational new animal drug exemption applies.

751×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

841×

RX DEVICE

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it is a prescription device that appears to not feature a prescription device legend as required by 21 CFR 801.109.

161×

DIRECTIONS

The article is subject to refusal of admission pursuant to section 801(a)(3) in that it is a device whose label appears to not bear adequate directions for use.

Refusal History

DateProductViolationsDivision
12/9/2020
78MRESOLUTION, SODIUM HYALURONATE
118NOT LISTED
3280FRNMFGREG
Division of Southeast Imports (DSEI)
8/2/2018
79LMHIMPLANT, DERMAL, COLLAGEN FOR AESTHETIC USE
237NO PMA
84RX DEVICE
Division of Southeast Imports (DSEI)
5/30/2014
89MOZACID, HYALURONIC, INTRAARTICULAR
237NO PMA
Division of Northern Border Imports (DNBI)
3/6/2012
56YBK99ANTIBIOTIC N.E.C.
118NOT LISTED
Cincinnati District Office (CIN-DO)
10/31/2011
54YMY99VITAMIN, MINERAL, PROTEINS AND UNCONVENTIONAL DIETARY SPECIALITIES FOR HUMANS AND ANIMALS, N.E.C.
75UNAPPROVED
Chicago District Office (CHI-DO)
1/22/2008
78MRESOLUTION, SODIUM HYALURONATE
2380NO PMA/PDP
Los Angeles District Office (LOS-DO)
5/9/2006
64WQP99IRRIGATION SOLUTION N.E.C.
118NOT LISTED
72NEW VET DR
New Orleans District Office (NOL-DO)
10/14/2003
78MRESOLUTION, SODIUM HYALURONATE
16DIRECTIONS
Seattle District Office (SEA-DO)

Frequently Asked Questions

What is Bloomage Biotechnology Corp., Ltd.'s FDA import refusal history?

Bloomage Biotechnology Corp., Ltd. (FEI: 3008240723) has 8 FDA import refusal record(s) in our database, spanning from 10/14/2003 to 12/9/2020.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Bloomage Biotechnology Corp., Ltd.'s FEI number is 3008240723.

What types of violations has Bloomage Biotechnology Corp., Ltd. received?

Bloomage Biotechnology Corp., Ltd. has been cited for 8 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about Bloomage Biotechnology Corp., Ltd. come from?

All FDA import refusal data for Bloomage Biotechnology Corp., Ltd. is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.